Novel Targets in Hypertension Therapy

Hypertension remains a leading risk factor for cardiovascular diseases, but traditional therapies often fail to adequately control blood pressure in all patients. This session will explore novel molecular targets for hypertension treatment, focusing on breakthroughs in understanding vascular remodeling, sympathetic nervous system regulation, and kidney function. Emerging therapies targeting receptors like endothelin and vasopressin, as well as new inhibitors of the renin-angiotensin-aldosterone system (RAAS), are showing promise. Advances in gene therapy, epigenetics, and drug repurposing are also offering new avenues to better manage hypertension, with a focus on precision medicine and minimizing side effects for diverse patient populations.

 

    Related Conference of Novel Targets in Hypertension Therapy

    May 05-06, 2025

    19th World Drug Delivery Summit

    Vancouver, Canada
    June 16-17, 2025

    3rd Global Online Summit on Nanoscience and Nanotechnology

    Zurich, Switzerland
    June 23-24, 2025

    38th World Congress on Pharmacology

    Paris, France
    August 18-19, 2025

    40th World Congress on Pharmacology and Therapeutics

    Valencia, Spain
    September 22-23, 2025

    Pharma Biotech Expo

    Toronto, Canada
    September 23-24, 2025

    10th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    November 20-21, 2025

    21st Annual Congress on Pharmacology and Toxicology

    Aix-en-Provence, France
    November 27-28, 2025

    4th World Congress on Precision and Personalized Medicine

    Zurich, Switzerland
    November 27-28, 2025

    13th International Conference on Clinical Trials

    Amsterdam, Netherlands
    November 27-28, 2025

    4th World Conference on Pharma Industry and Medical Devices

    Zurich, Switzerland

    Novel Targets in Hypertension Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in